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Abstract
Inadequate or inappropriate implantation and placentation during the establishment of human pregnancy is thought to
lead to first trimester miscarriage, placental insufficiency and other obstetric complications. To create the placental blood
supply, specialized cells, the ‘extravillous trophoblast’ (EVT) invade through the differentiated uterine endometrium (the
decidua) to engraft and remodel uterine spiral arteries. We hypothesized that decidual factors would regulate EVT function
by altering the production of EVT membrane and secreted factors. We used a proteomics approach to identify EVT
membrane and secreted proteins regulated by decidual cell factors. Human endometrial stromal cells were decidualized in
vitro by treatment with estradiol (10
28 M), medroxyprogesterone acetate (10
27 M) and cAMP (0.5 mM) for 14 days.
Conditioned media (CM) was collected on day 2 (non-decidualized CM) and 14 (decidualized CM) of treatment. Isolated
primary EVT cultured on Matrigel
TM were treated with media control, non-decidualized or decidualized CM for 16 h. EVT CM
was fractionated for proteins ,30 kDa using size-exclusion affinity nanoparticles (SEAN) before trypsin digestion and HPLC-
MS/MS. 43 proteins produced by EVT were identified; 14 not previously known to be expressed in the placenta and 12
which had previously been associated with diseases of pregnancy including preeclampsia. Profilin 1, lysosome associated
membrane glycoprotein 1 (LAMP1), dipeptidyl peptidase 1 (DPP1/cathepsin C) and annexin A2 expression by interstitial EVT
in vivo was validated by immunhistochemistry. Decidual CM regulation in vitro was validated by western blotting:
decidualized CM upregulated profilin 1 in EVT CM and non-decidualized CM upregulated annexin A2 in EVT CM and pro-
DPP1 in EVT cell lysate. Here, non-decidualized factors induced protease expression by EVT suggesting that non-
decidualized factors may induce a pro-inflammatory cascade. Preeclampsia is a pro-inflammatory condition. Overall, we
have demonstrated the potential of a proteomics approach to identify novel proteins expressed by EVT and to uncover the
mechanisms leading to disease states.
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Introduction
During the establishment of pregnancy, a human blastocyst
must implant into the uterine endometrium to facilitate the
formation of a functional placenta. Inadequate or inappropriate
implantation and placentation is thought to lead to first trimester
miscarriage, placental insufficiency and other obstetric complica-
tions [1,2]. To form a functional placenta, specialized cells, the
‘extravillous trophoblast’ (EVT) engraft and remodel uterine spiral
arteries, creating the placental blood supply at the end of the first
trimester [3].
The local endometrial environment is likely to play a key role in
regulating trophoblast invasion [3]. Prior to implantation and in
preparation for pregnancy, stromal cells of the human uterine
endometrium undergo ‘decidualization’. Decidualization describes
the dramatic differentiation of endometrial stromal cells into
decidual cells, which become rounded with altered secretory and
ECM expression [4]. Decidualization involves the categorical
reprogramming of endometrial stromal cells such that different
genes are expressed at different stages of the differentiation process
[5]. In women, decidualization begins spontaneously in stromal
cells adjacent to spiral arterioles during the mid-secretory phase of
the menstrual cycle (5
th–10
th day after luteinizing hormone surge)
in response to progesterone and regardless of the presence of a
functional blastocyst. If implantation occurs, decidualization
intensifies and continues to form the decidua of pregnancy [6].
The decidua is thought to regulate trophoblast invasion and
placental formation by regulating expression of locally produced
factors including cytokines, integrins and major histocompatibility
complex factors [4]. The critical importance of decidualization for
the formation of a functional placenta in mice has been
unequivocally demonstrated by genetically-modified mouse studies
where decidualization defects lead to unregulated trophoblast
invasion [7] and/or pregnancy failure [7,8,9]. However, unlike
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implantation, thus the systems are not analogous. Regardless,
recent evidence in women indicates that decidualization is also
important in the formation of a functional placenta, with impaired
decidualization associated with recurrent miscarriage, preeclamp-
sia (PE) and placenta accreta [10,11,12].
The mechanisms by which the decidua might regulate EVT
function are not well understood. Many studies have examined the
role of leukocytes, particularly uterine natural killer cells in EVT
function [13,14], however the role of decidual cells themselves is
understudied. In vitro, conditioned medium from isolated cells of
1
st trimester decidual explants impairs invasion of HTR8SV/neo
cells (immortalized human EVT [15]) compared to culture media
alone [16]. Conditioned media collected from decidual stromal
cells isolated from 1
st trimester decidua demonstrates concentra-
tion dependent invasion of B6Tert cells (immortalized human
cytotrophoblast cells [15]) [17]. This invasive capability correlated
with the MMP2 activity in these cells [17]. However, in neither of
these studies was the control media conditioned with control cells.
Recently, Godbole [18] reported enhanced invasion of the
choriocarcinoma cell lines JEG-3 and ACH-3P [15] following
treatment with conditioned media from primary stromal cells
decidualized in vitro compared to the pre-decidualized cells.
Further, AC1M88 (fusion of JEG-3 and term trophoblasts [15])
spheroids showed enhanced expansion when cultured on top of
primary stromal cells decidualized in vitro compared to non-
decidualized cells [19]. These studies strongly indicate that
decidualized stromal cells regulate EVT function, however they
are not conclusive and importantly, do not utilize primary EVT.
We hypothesised that decidual factors regulate EVT function by
altering the production of EVT membrane and secreted proteins.
We aimed to identify and validate EVT membrane and secreted
proteins regulated by decidualized stromal cells. To our knowl-
edge, this is the first study to investigate how decidual cell
secretions regulate trophoblast protein production.
Materials and Methods
Tissue collection
This study was approved by the Southern Health Human
Research and Ethics Committee (#09317B; #06014C). Written
and informed consent was obtained from each patient before
surgical intervention.
Trophoblast isolation. Normal first trimester placental
tissue was collected from healthy women undergoing elective
termination of pregnancy (amenorrhea: 7–12 weeks). Tissues were
washed in 0.9% saline and transferred to DMEM/F12 Ham
media (D8437, Sigma-Aldrich) before transportation to the
laboratory for further processing.
First trimester primary cytotrophoblast were isolated as
previously described [20]. The isolated cytotrophoblast were
plated on growth factor reduced Matrigel
TM (1:5 dilution in
serum-free media; BD Biosciences # 356230) to induce the EVT
phenotype [21]. The purity of the isolated EVT was confirmed by
immunohistochemistry for HLAG. Briefly, cells were grown on
chamber slides coated with Matrigel for 72 h before being fixed in
70% ethanol for 10 min and allowed to air dry. Cells were re-
hydrated in dH2O for 5 min before exogenous peroxidise blocked
by incubation in 3% (v/v) H2O2 for 15 min. Cells were blocked in
10% normal horse serum, 2% normal human serum for 30 min
before primary antibody (HLAG, 0.5 mg/ml, Pharminagen,
#557577) was applied in block overnight at 4uC. Cells were
washed in Tris buffered saline (TBS) before incubation with a
biotinylated horse anti-mouse IgG (1:200; Vector) secondary
antibody for 30 min at RT. This was followed by 30 min
incubation with streptavidin-biotin-peroxidase complex ABC
(Vector) before HLAG visualized using diaminobenzidine tetra-
hydrochloride substrate (Dako). Cells were counterstained with
Harris haematoxylin (Sigma). This isolation method resulted in
80–95% EVT (HLAG positive cells; Figure 1A&B).
Stromal cell isolation. Endometrial biopsies were collected
by dilatation and curettage from fertile women scheduled for tubal
ligation or undergoing testing for tubal patency during days 8–21
of a normalised 28 day menstrual cycle. Tissues were assessed by a
pathologist and had no obvious endometrial pathology. The
women had no steroid treatment or other medication for at least 2
months before the collection of tissue.
Human endometrial stromal cells (HESC) were isolated by
enzymatic digestion and filtration as described previously [22],
resulting in a 97% pure stromal cell culture.
In vitro decidualization. HESC (cultured from individual
endometrial biopsies) were grown to confluence (maximum time to
confluence 5 days) in a T25 culture flask (NUNC) in medium
(DMEM/F12 [Gibco] supplemented with 10% charcoal stripped
Fetal Calf Serum [csFCS; Gibco,], 1% antibiotics and antimycotic
[penicillin, streptomycin, amphoceterin B; Gibco] and 1% L-
glutamine [Sigma]) in a 5% CO2 incubator at 37uC.
Once confluent, the medium was replaced (experimental day
[D] 0) with low-serum medium (DMEM/F12+2% csFCS, 1%
antibiotics and antimycotic and 1% L-glutamine). Under these
conditions cell proliferation is minimal [23,24,25]. Cells were
Figure 1. Purity of isolated extravillous trophoblast (EVT) and
prolactin secretion by human endometrial stromal cells
following decidualization treatment. A. HLAG immunolocalization
in isolated EVT. B. Negative (IgG) control for isolated EVT. C. Prolactin
secretion by human endometrial stromal cells induced to decidualize in
vitro (estrogen [10
28 M], medroxyprogesterone acetate [10
27 M] and
cyclic adenosine monophosphate [0.5 mM]) for 2 (non-decidualized)
and 14 (decidualized) days. Conditioned media from decidualized
samples containing ,1.5 mIU/mg or .5 mIU/mg prolactin (dotted line)
were excluded from further studies.
doi:10.1371/journal.pone.0031418.g001
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28 mol/L estradiol 17b (Sigma),
10
27 mol/L medroxyprogesterone acetate (MPA; P-0130, Sigma)
plus 0.5 mM cyclic adenosine monophosphate (cAMP; Sigma) for
14 days. The media containing treatments was replenished on D2,
4, 7, 9 & 12. Conditioned media (CM) was collected on D2 (non-
decidualized CM) and D14 (decidualized CM), centrifuged at
1606g to remove any non-adherent cells and stored at 280uC. On
D14 cells were lysed and homogenized in ice-cold universal lysis
buffer (50 mM Trizma Base [Sigma] pH7.4, 150 mM NaCl,
2 mM EDTA, 2 mM EGTA, 25 mM NaF, 0.2% Triton X-100
[Sigma], 0.3% Nonidet P-40 [Sigma]) containing Protease
Inhibitor Mixture Set III (1:500; Calbiochem) and stored at
280uC. The protein concentration was assayed by commercial kit
(BCA, Pierce). HESC prolactin (PRL) secretion was quantitatively
measured in conditioned media by ELISA (Bioclone Aust. Pty Ltd,
Marrickville, NSW, Australia) and the level of PRL secretion was
taken as a measure of decidualization [26]. PRL secretion by non-
decidualized HESC was undetectable (Figure 1C). PRL secretion
by decidualized HESC was 3.10661.362 mIU/mg with a range
of 0.4714–6.676 mIU/mg (Figure 1C). Decidualized HESC
secreting ,1.5 and .5 mIU/mg PRL were excluded from further
experiments to standardise the level of decidualization across
cultures.
EVT treatment with HESC CM
EVT cultured in a 6 well plate on top of matrigel were treated
overnight (16 h) with 500 ml low-serum media or non-decidualized
(D2) or decidualized (D14) HESC CM. As a control, each of
treatments was also incubated for 16 h in wells coated with
Matrigel. These controls were also subjected to the proteomics
analysis detailed below to allow exclusion of proteins expressed by
the decidua. The EVT/Matrigel CM was centrifuged at 1606g to
remove cell debris and stored at 280uC. Cell lysates were collected
and protein quantified as described above.
Conditioned media fractionation. Proteins in the CM with
a molecular weight of ,30 kDa were fractionated from the
remaining media using size-exclusion affinity hydrogel
nanoparticles (SEAN) as previously described [27]. Briefly, total
protein was precipitated from the CM by incubation in 100%
acetone (1 CM : 3 acetone) at 220uC overnight. The protein pellet
was resuspended in 10 mM 2-(N-morpholino) ethanesulfonic acid,
pH 6 before addition of 3 mg SEAN and incubation at RT for
20 min followed by centrifugation to pellet the SEAN. After
washes, the fractionated proteins were eluted from the SEAN and
concentrated in a centrifugal vacuum concentrator (Eppendorf).
Protein identification. Proteins eluted from the SEAN were
reduced with 10 mM DTT (Calbiochem) at 56uC for 30 minutes
and then thiol groups alkylated with 50 mM iodoacetic acid
(Fluka) 30 minutes at RT. Proteins were digested overnight at
37uC with 375 ng trypsin (Worthington). The extracted peptide
solution (0.1% formic acid) were then concentrated to
approximately 10 ml by centrifugal lyophilisation using a
SpeedVac AES 1010 (Savant). Extracted peptides were then
injected and fractionated by nanoflow reversed-phase liquid
chromatography on a nano LC system (1200 series, Agilent,
USA) using a nanoAcquity C18 150 mm60.15 mm I.D. column
(Waters, USA) developed with a linear 60-min gradient with a flow
rate of 0.5 ml/min at 45uC from 100% solvent A (0.1% Formic
acid in Milli-Q water) to 100% solvent B (0.1% Formic acid, 60%
acetonitrile, (Mallinckrodt Baker, Phillipsburg, NJ, USA) 40%
Milli-Q water). The nano HPLC was coupled on-line to an LTQ-
Orbitrap mass spectrometer equipped with a nanoelectrospray ion
source (Thermo Fisher Scientific) for automated MS/MS. Data
dependent MS analysis was performed by acquiring one FTMS
scan followed by MS2 on the top five most intense ions. Dynamic
exclusion was enabled at repeat count 1, exclusion list size 500,
exclusion duration 180 s, and exclusion mass width+/21.5 m/z.
Collision induced dissociation was performed by setting the ion
isolation width at 2 m/z, normalized collision energy at 35%,
activation Q at 0.25 and an activation time at 30 ms.
Spectra were exported in mascot generic file format (.mgf) and
analyzed using the Mascot search engine. Standard search
parameters included a peptide mass tolerance of 1.5 Da, peptide
fragment tolerance of 0.8 Da, peptide charge of +2o r+3 and up to
1 missed cleavage allowed.
Identified proteins were cross-checked between the 6 groups
(EVT treated with media alone, EVT treated with ND CM, EVT
treated with D CM, media alone, ND CM and D CM). Proteins
identified in the media alone control were identified as proteins in
the media or expressed by matrigel and excluded from all other
groups. Proteins identified in the ND or D CM controls were
identified as proteins expressed by HESC and excluded from all
other groups. Proteins identified in EVT treated with media
alone were identified as proteins expressed by EVT in vitro
regardless of treatment and excluded from all other groups.
Proteins identified in EVT treated with both ND and D CM were
identified as proteins expressed by EVT in response to CM and
excluded.
Validation
Immunohistochemistry. Formalin-fixed decidua and
placenta sections (5 mm) on poly-l-lysine (Sigma) coated glass
slides were dewaxed in histosol (2610 min) and rehydrated in
ethanol. Antigen retrieval in 0.01 M Citrate buffer (pH 6, profilin
1, annexin A2, LAMP1) or 1.25% Trypsin (DPP1) before proteins
were co-localized with HLAG using EnVision
TM G|2 Doublestain
System (Rabbit|Mouse, DAKO, #K5361) as per the
manufacturer’s instructions. The primary antibodies were
incubated at 37uC for 10 min at the following concentrations:
profilin 1 0.6 mg/ml (Santa Cruz Biotechnology, sc-137236);
annexin A2 0.1 mg/ml (Abcam, #ab41803); DPP1 5 mg/ml
(Abcam, #ab49233); LAMP1 3.3 mg/ml (Biolegend, #328602);
HLAG 1 mg/ml (Pharmingen, #557577). Negative controls of
mouse or rabbit IgG (both DAKO) were applied at the same
concentration as the primary antibodies.
Western blotting. EVT cell lysates (n=6) were treated,
collected and assayed for total protein as described above. 15 mg
total protein (or 1 mg for annexin A2) or conditioned media
(28 ml/well, or 10 ml for annexin A2) was resolved on a 1.5 mm
11% SDS/PAGE gel, transferred to Hybond-P PVDF membranes
(GE Healthcare) and blocked in 0.1% Tween, 5% skim milk in
TBS. Membranes were incubated overnight at 4uC with the
primary antibody (all 1:1000), except GAPDH (HRP-conjugated,
Cell Signaling Technology, #3683S, 1:2000) which was incubated
for 1 h at RT. After washes in TBS and 0.1% Tween-20 (BioRad)
TBS, HRP-conjugated secondary antibody (profilin 1: sheep anti-
mouse, Amersham, 1:3000, annexin A2 and DPP1, goat anti-
rabbit, 1:5000, secondary antibody not required for GAPDH) was
applied, washed again, then the ECL Plus Detection System (GE
Healthcare) was applied. Membranes were exposed to
autoradiography film (Hyperfilm ECL; GE Healthcare) for
between 10 sec and 5 min. Films were scanned and
densitometry was performed using Adobe Photoshop. To
account for the fact that total protein varied between treatments
and a loading control cannot be assigned for conditioned media,
the densitometry of the conditioned media was normalized to total
cellular protein.
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All statistical analyses were performed using GraphPad Prism.
Densitometry of western blot data was analysed by paired t-test.
Results
Proteomics identified unique proteins in EVT CM in response
to treatment with non-decidualized or decidualized CM
Mass spectrometry revealed 43 proteins produced by EVT
following the various treatments (Table S1). Of 18 proteins
produced by EVT in vitro, 2 were previously unknown to be
expressed by cells of the placenta, including EVT (Table S1). Two
of the 16 known proteins have previously been associated with
pregnancy pathologies (Table S1 [28,29]).
13 unique proteins were found expressed by EVT in response to
treatment with non-decidualized CM, 6 were previously unknown
to be expressed by EVT (Table S1) and of the 7 known proteins, 4
are dysregulated in preeclampsia and 1 is associated with
endometrial cancer (Table S1 [30,31,32,33,34]). EVT treated
with decidualized CM expressed 12 unique proteins; 6 previously
Table 1. Proteins chosen for validation by immunohistochemistry and western blot.
Protein
Accession
Number MW (kDa)
Known
placenta
Detected by
proteomics in
Unique
peptides
(#)
Sequence
coverage
(%)
Profilin 1 P07737 15 N
Media CM 1 11.4
ND CM 2 20.0
D CM 4 41.4
Annexin A2 P07355 38 Y
ND CM 7 25.4
Dipeptidyl peptidase 1 P53634 51 N
ND CM 1 3.02
Lysosome-associated membrane
glycoprotein 1
P11279 44 Y D CM 2 4.8
doi:10.1371/journal.pone.0031418.t001
Figure 2. Profilin 1 (brown) and HLAG (pink) co-localization in placental villous (A–C) and decidua basalis (D–F). A. Profilin 1 localized
to cells within the stroma of the villous tip, but not the syncytiotrophoblast (s). B. Profilin 1 localized to leukocytes (arrowheads) in the villous tips. C.
Profilin 1 and HLAG co-localilzed to extravillous trophoblast (EVT, arrow) in the cell column (cc). D. Profilin 1 localized to the glandular epithelium (ge),
and HLAG positive cells (EVT, arrows) surrounding blood vessels (bv) and HLAG negative cells (arrowheads) in the decidua basalis. E. Profilin 1
localized to the ge, EVT (arrows) and HLAG negative cells (arrowheads) in the decidua basalis. F. Profilin 1 and HLAG co-localizaation to EVT (arrows) in
the decidua basalis. Profilin 1 was also expressed on leukocytes (HLAG negative cells, arrowheads). G. Negative (IgG) control for placental villous
tissue. H. Negative (IgG) for decidua. Scale bar: 50 mm.
doi:10.1371/journal.pone.0031418.g002
Decidual Factors Alter Trophoblast Proteins
PLoS ONE | www.plosone.org 4 February 2012 | Volume 7 | Issue 2 | e31418unknown to be expressed by EVT and 5 of the 6 known proteins
are dysregulated in either preeclampsia (3), IUGR (1) or in IVF
and ICSI pregnancies (1; Table S1 [35,36,37,38,39]).
Four identified proteins were chosen for validation (Table 1).
These proteins were chosen as they are all secreted and have
known functions in other cell types which are likely important
during EVT invasion into the decidua.
Profilin 1
Profilin 1 localised to iEVT in decidua basalis. Profilin 1
immunolocalized to leukocytes (Figure 2A&B) and EVT in the cell
column (Figure 2C) but not to cytotrophoblast or
syncytiotrophoblast in the placental villous. Profilin 1 localized
to the uterine glandular epithelium (Figure 2D&E), iEVT
surrounding remodelled blood vessels (Figure 2D–F) and
leukocytes in the decidua (Figure 2E&F).
Decidual CM increased profilin 1 secretion. Profilin 1
was detected in EVT cell lysates and CM by western blot
(Figure 3A&B). Profilin 1 levels in EVT CM were significantly
higher in decidualized CM treated EVT compared to non-
decidualized CM treated (Figure 3B&C; p,0.05). Profilin 1 was
not detected in HESC CM (data not shown). No effect of the week
of gestation from which the EVT were isolated was observed.
Annexin A2
Annexin A2 localized to iEVT in decidua basa-
lis. Annexin A2 localized to the syncytiotrophoblast
(Figure 4A&B) and some EVT in the cell column (Figure 4C),
but not to cytotrophoblast or leukocytes in the placental villous.
Annexin A2 localized to endothelial cells in blood vessels
(Figure 4D&E) and iEVT in the decidua (Figure 4E&F).
Non-decidualized CM increased annexin A2 secre-
tion. Annexin A2 was detected in EVT cell lysates and CM
by western blot (Figure 5A&B). HESC CM treatment had no
effect on annexin A2 protein levels in EVT cell lysates (Figure 5A).
Two bands of annexin A2 (33 and 36 kDa) were observed in CM
of EVT isolated from weeks 7 and 8 of gestation but not in CM of
EVT isolated from weeks 10 and 11 of gestation (Figure 5B).
Secreted annexin A2 protein (36 kDa) in EVT CM was
significantly higher (p,0.05) following treatment with non-
decidualized CM compared to control (media alone), however
the variability between samples was large (n=6; Figure 5C). Our
data suggests the effect of non-decidualized CM was found mainly
in EVT isolated from weeks 10 and 11 of gestation (Figure 5B).
Dipeptidyl peptidase 1 (DPP1)
DPP1 localized to iEVT in decidua basalis. DPP1 immu-
nolocalized to some areas of the syncytiotrophoblast
(Figure 6A&B), leukocytes (Figure 6B) and to cohorts of EVT in
the cell column (Figure 6C) but not to cytotrophoblasts. In the
decidua, DPP1 localized to the glandular epithelium
(Figure 6D&E) and to iEVT surrounding blood vessels
(Figure 6D,F&G). Glandular epithelial and iEVT localization
was cytoplasmic, although in EVT the cytoplasmic localization
was predominantly around the nucleus.
Non-decidualized CM increased proDPP1 produc-
tion. DPP1 could not be detected in EVT CM by western
blotting (data not shown). In EVT cell lysates 5 bands were visible
(Figure 7A); 52 kDa and 51 kDa (pro-), 34 kDa (mature), 24 kDa
(active) and 7 kDa (mature cleavage) DPP1. By densitometry we
found a significant increase in proDPP1 protein in EVT cell lysate
following treatment with non-decidualized CM (Figure 7B;
p,0.05), but not decidualized CM (p.0.05) compared to media
control. There was no effect of HESC CM on mature or active
DPP1 (25 kDa; Figure 7C&D). The mature cleavage form of
DPP1 (7 kDa) was only observed in EVT cell lysates from two of
three women following treatment with HESC CM: in both women
the mature cleavage form was present following treatment with
non-decidualized CM and in only one woman it was found
following treatment with decidualized CM (Figure 7A). All three
samples were from EVT isolated from weeks 7–8 of gestation.
Lysosome associated membrane glycoprotein 1 (LAMP1)
LAMP1 localized to iEVT in decidua basalis. LAMP1
immunolocalized to the syncytiotrophoblast (Figure 8A&B) and
leukocytes (Figure 8B) in the placental villous and to EVT in the
cell column (Figure 8C). In the decidua, LAMP1 localized to
occasional cells in the glandular epithelium (Figure 8D), HLAG
(EVT marker) negative cells surrounding the glandular epithelium
and unremodelled blood vessels (Figure 8D&E) and iEVT
surrounding remodelled blood vessels (Figure 8F&G).
LAMP1 could not be detected in EVT CM or cell lysates by
western blotting (data not shown).
Discussion
Here, for the first time, we identified proteins expressed by EVT
in response to HESC-secreted factors. Our novel in vitro model
identified proteins previously associated with diseases of pregnancy
including preeclampsia suggesting our model can identify factors
likely to be important in the pathogenesis of these diseases. Our
Figure 3. Profilin 1 in extravillous trophoblast cell lysate and
conditioned media following treatment with media alone (M),
non-decidualized (ND) or decidualized (D) human endometrial
stromal cell conditioned media (n=5). A. Western blot showing
profilin 1 and GAPDH loading control in EVT lysates. B. Western blot
showing profilin 1 in EVT conditioned media. C. Densitometry of profilin
1 from conditioned media. The ratio of profilin 1:total cellular protein
has been normalized to media control. *, significant difference to ND,
p,0.05.
doi:10.1371/journal.pone.0031418.g003
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decidualized (ND) or decidualized (D) human endometrial stromal cell conditioned media (n=6). A. Western blot showing annexin A2
and GAPDH loading control in EVT lysates. B. Western blot showing annexin A2 in EVT conditioned media. Shown are representative blots of annexin
A2 in EVT isolated from gestational weeks 7–8 (n=3) and 10–11 (n=2). Two bands (36 & 33 kDa) for annexin A2 were observed in the conditioned
media from EVT isolated from gestational weeks 7–8. C. Densitometry of annexin A2 from conditioned media (all weeks of gestation; n=6). The ratio
of annexin A2:total cellular protein has been normalized to media control. *, signficant difference to M, p,0.05.
doi:10.1371/journal.pone.0031418.g005
Figure 4. Annexin A2 (brown) and HLAG (pink) co-localization in placental villous (A–C) and decidua basalis (D–F). A. Annexin A2
localization in the placental villous. B. Annexin A2 localized to the syncytiotrophoblast (s). C. Annexin A2 and HLAG co-localilzed to extravillous
trophoblast (EVT, arrows) in the cell column (cc). D. Annexin A2 localization in the decidua basalis. E. Annexin A2 localized to endothelial cells of blood
vessels (bv) and to iEVT (arrow) in the decidua basalis. F. Annexin A2 and HLAG co-localizaation to EVT (arrows) in the decidua basalis. G. Negative
(IgG) control for placental villous. H. Negative (IgG) for decidua. Scale bar: 50 mm.
doi:10.1371/journal.pone.0031418.g004
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expressed by EVTs. We demonstrated that EVT expression of
profilin 1, annexin A2 and proDPP1 was altered following
treatment with HESC CM, suggesting that the degree of
decidualization is critical for decidual-EVT crosstalk during
EVT invasion. Further, our data suggests that non-decidualized
factors may provoke EVTs to initiate a pro-inflammatory cascade,
providing a potential mechanism for the pro-inflammatory state
observed in preeclampsia.
Recent studies have suggested that women with preeclampsia
have impaired decidualization [12]. Our identified proteins
suggest that decidual regulation of EVT protein expression may
be associated with the development of preeclampsia, however,
future studies are required to validate the regulation of these
proteins and their function. By fractionating our sample to identify
proteins ,30 kDa in size, we aimed to identify functional and
regulatory proteins. The main functional groups of proteins
identified by our proteomic approach were proteases/enzymes,
membrane bound proteins, metal ion binding proteins, and
proteins involved in redox regulation. Interestingly, treatment with
decidualized CM was associated with an increase in the number of
cell membrane proteins expressed by EVT (Table S1) whereas
treatment with non-decidualized CM was associated with an
increase in the number of proteases expressed by EVT (Table S1).
A recent study showed CECAM1 (CD66a) expression by
AC1M88 spheriods is enhanced following co-culture with
decidualized HESC [19], however to our knowledge this is the
first study to suggest that non-decidualized factors regulate
protease expression by EVTs.
The EVT proteins identified here included secreted proteins
(profilin 1, annexin A2) and cell surface proteins (profilin 1,
annexin A2, DPP1, LAMP1). We expected to find cell surface
proteins in our CM [40,41] as our methodology did not exclude
cell debris or exosomes given the likely importance of membrane
proteins in the regulation of trophoblast invasion. While proteomic
analysis of purified EVT plasma membrane would be ideal, we
were limited by cell number; isolating purified plasma membrane
from primary EVT requires a prohibitively large number of cells.
The decidualization CM used in this study was chosen to reflect
the degree of decidualization found in HESC during the 1
st
trimester; when EVT invade through the decidua and into the top
3
rd of the myometrium. Decidual biopsies from weeks 8–10 of
gestation secrete 0.3 mIU/mg prolactin in 24 h [42]. Here,
prolactin secretion was 3.1 mIU/mg over 48 h, however it should
be noted that this was from a purified population of HESC; in a
decidual biopsy, less than 50% of the tissue is decidual cells; the
tissue includes leukocytes (40% of cells), endothelial cells, smooth
muscle and connective tissue. To standardize the degree of
decidualization we also excluded under- and over-decidualized
CM (,1.5, .5 mIU/mg).
Profilin 1 is an G-actin-binding protein which regulates actin
dynamics on the plasma membrane [43] by regulating actin
polymerization [44]. Profilin 1 is critical for normal cell
proliferation and differentiation and is vital for actin-based cell
motility, cytokinesis, neuronal differentiation and regulation of
membrane trafficking and nuclear transport [44]. Here, decid-
ualized CM up-regulated profilin 1 levels in EVT CM, suggesting
that decidualized CM induced profilin 1 secretion. Profilin 1
Figure 6. Dipeptidyl peptidase 1 (DPP1; brown) and HLAG (pink) co-localization in placental villous (A–C) and decidua basalis (D–
G). A. DPP1 localization in placental villous. B. DPP1 localized to some areas of syncytiotrophoblast (s). C. DPP1 and HLAG co-localilzed to extravillous
trophoblast (EVT) in the cell column (cc) (arrows). DPP1 staining was predominantly peri-nuclear in EVT. DPP1 localized to leukocytes in the placental
villous stroma (arrowheads). D. DPP1 localization in the decidua. E. DPP1 localized to the glandular epithelium (ge), with peri-nuclear localization
observed in some cells (*). F. DPP1 localized to iEVT (arrows) surrounding remodelled blood vessels (bv). G. DPP1 localization in iEVT (arrow). DPP1
localization in iEVT was predominantly peri-nuclear. H. Negative (IgG) control for placental villous. I. Negative (IgG) control for decidua. Scale bar:
50 mm.
doi:10.1371/journal.pone.0031418.g006
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radiation induced senescence [45]. In vivo, EVT are non-
proliferative; perhaps decidual factors induce senescence in
EVT. Certainly, profilin 1 is thought to be a tumor suppressor:
it is downregulated in aggressive forms of cancer compared to
normal cells [46,47] and inhibits cell functions required for
metastasis including proliferation and migration [46,48,49,50].
EVT are also highly motile and as an actin-binding protein,
profilin 1 regulates cell motility, however the exact function of
profilin 1 in the regulation of motility is not clear. Although
profilin 1 inhibits migration in breast cancer cells, profilin 1
stimulates migration of HUVEC and mesenchymal stem cells
[51,52,53] and is enriched at the dynamic plasma membranes of
migrating or spreading cells [43]. It remains to be determined how
the up-regulation of profilin 1 induced by decidualized CM
modulates EVT function; the literature currently suggests profilin
1 regulates motility differently between cancerous and normal
cells.
Annexin A2 is a calcium-dependent phospholipid binding
protein which is present in intracellular, membrane and secreted
forms [54]. It has roles in membrane fusion and signal
transduction [55] and is over-expressed in a variety of cancers
[56,57]. Secreted and surface annexin A2 interacts with cell matrix
and proteases to regulate cell migration and adhesion [57,58,59]
and it is involved in macrophage activation [60,61]. Induction or
redistribution of annexin A2 has been demonstrated in response to
heat shock, hypoxia, cell redox state, mechanical stress and mild
osmotic shock [61]. Annexin A2 has previously been identified in
the syncytiotrophoblast in vivo [58,62] and in vitro it is up-
regulated by hypoxia in cytotrophoblasts [63] and syncytializing
BeWo cells [55], leading to the suggestion that it is part of a
defence system against hypoxia [55].
This study is the first to identify annexin A2 in EVT. We found
that non-decidualized CM up-regulated secreted/cell surface
annexin A2 in EVT isolated from weeks 10 and 11 of gestation.
Cell surface expression of annexin A2 is required for invasion and
metastasis in cancer [57,64]. In monocytes and macrophages,
surface and soluble annexin A2 (in a tetramer with S100A10) acts
as a receptor for plasmin(ogen), which binds then cleaves annexin
A2, initiating downstream signalling via multiple pathways
including JAK/STAT, MAPK and NF-kb [60,65]. This results
in the up-regulation of proinflammatory cytokines [60,65] and
thus an inflammatory response [61]. Here we found the cleaved
form of annexin A2 (33 kDa) present in CM from EVT isolated
from weeks 7 and 8 of gestation but not from weeks 10–12 of
gestation, suggesting that plasmin was only active in EVT from
weeks 7 and 8 of gestation. Overall our data suggests that surface
expression of annexin A2 was normal in EVT from weeks 7 and 8
and likely involved in regulating EVT cell invasion as occurs in
uNK cells [66], but that in weeks 10 to 11, annexin A2 surface
expression may be an indicator of stress induced by the non-
decidualized CM. Certainly, the amount of surface annexin A2
detected by western blot was considerably lower in weeks 10 and
11 compared to 7 and 8. Since plasmin is expressed by eg. uNK
cells [66], aberrant surface expression of annexin A2 could lead to
abnormal proinflammatory signalling cascades.
DPP1, also known as cathepsin C, is a cysteine protease
involved in the activation of pro-inflammatory serine proteases
[67,68], the processing of lysosomal cathepsins and the degrada-
tion of intracellular proteins [69]. DPP1 function is best
characterised in the immune system: DPP1 deficient mice and
human immune cells show reduced NK and T-cell cytotoxic
activity [70,71]. DPP1 activity is highest in lymphocytes with
cytolytic potential and myeloid cells [72]. DPP1 activation of
granzymes [67] and perforin is thought important in ‘involuntary
apoptosis’, whereby target cells are killed without activation of
death receptors on the target cell surface [73]. Activation of serine
Figure 7. Dipeptidyl peptidase 1 (DPP1) in extravillous
trophoblast cell lysate following treatment with media alone
(M), non-decidualized (ND) or decidualized (D) human endo-
metrial stromal cell conditioned media (n=6). A. Western blot
showing DPP1 and GAPDH loading control in EVT lysates. B.
Densitometry of the 52 & 51 kDa DPP1 band from EVT cell lysates
(n=3). The ratio DPP1:GAPDH was normalized to media only control. C.
Densitometry of the 34 kDa DPP1 band from EVT cell lysates (n=3). The
ratio DPP1:GAPDH was normalized to media only control. D.
Densitometry of the 25 kDa DPP1 band from EVT cell lysates (n=3).
The ratio DPP1:GAPDH was normalized to media only control. *,
significant difference to M, p,0.05.
doi:10.1371/journal.pone.0031418.g007
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DPP1 has functions in cell invasion and inflammation [71]. DPP1
transcript has been identified in the placenta [74] however this is
the first study to identify DPP1 protein in the placenta. Here we
found 5 distinct bands for DPP1: 52 and 51 kDa, the pro-form of
DPP1 [75]; 34 kDa, the mature form of DPP1 [76,77]; 25 kDa,
the active form of DPP1 [67] and 7 kDa, the mature cleavage
form of DPP1. In this study, proDPP1 was up-regulated by
treatment with non-decidualized CM and the mature cleavage
form (7 kDa) was found only following treatment with HESC CM.
Capthesins are typically localized to lysosomes in the perinuclear
region [71] – which we observed here in iEVT and glandular
epithelial cells. During cancer development, cathepsins are often
translocated to the cell surface or are secreted where they can act
as proteases [71]. This has not been demonstrated for DPP1,
however it is interesting in light of our proteomics observation that
DPP1 was found only in CM following treatment with non-
decidualized CM. Certainly, treatment with non-decidualized CM
upregulated DPP1 in EVT cell lysates; we were unable to detect
DPP1 in EVT CM by western blotting and thus were unable to
confirm the regulation of cell surface DPP1 by non-decidualized
CM. Overall, our data suggests that the protease activity of DPP1
may be enhanced by non-decidualized CM.
LAMP1, also known as CD107a, was recently identified in
EVT [78] where its expression correlated with the ability of EVT
to resist infection from Listeria monocytogenes [78], suggesting that
EVT may have a bactericidal phenotype. Certainly, NK cells
which express LAMP1 are ‘degranulating’, ie. they are secreting
antimicrobial cytotoxic molecules [79,80]. Our co-localization
data showed HLAG negative, LAMP1 positive cells in the
decidua, particularly surrounding un-remodelled blood vessels
and the glandular epithelium. These cells did not co-localize with
CD45 or CK7 (data not shown), suggesting that these cells are
not leukocytes or HLAG negative trophoblast cells. It is
interesting to speculate that these cells may be decidual cells
involved in the removal of smooth muscle from around spiral
arteries.
Here, using a novel in vitro and proteomics approach we have
identified a number of proteins which were previously unknown to
be expressed by EVT. This approach also identified a number
proteins previously associated with diseases of pregnancy, in
particular preeclampsia, suggesting that this approach can identify
proteins which may have diagnostic or therapeutic potential for
targeting these diseases. Previous studies have demonstrated that
proteins which are produced at the fetal-maternal interface and
regulate trophoblast invasion can be detected and in fact are
dysregulated in maternal serum prior to disease onset [81,82].
Profilin 1, annexin A2 and DPP1 were identified for the first time
in EVT and immunolocalized to interstitial EVT in 1
st trimester
decidua and placental villous (n=5/6 per group). Further, the
expression of profilin 1, annexin A2 and proDPP1 was regulated
by HESC CM, indicating that the degree of decidualization may
be important for EVT protein production. Interestingly, the two
proteins identified as being up-regulated by non-decidualized CM
(annexin A2 and DPP1) are both associated with the activation of
serine proteases and both induce a pro-inflammatory response,
indicating that impaired decidualization may cause excess
inflammation during iEVT invasion.
Overall, we have demonstrated that our unique culture method
coupled with a proteomics approach has significant potential to
Figure 8. Lysosome associated membrane glycoprotein 1 (LAMP1; brown) and HLAG (pink) co-localization in the placental villous
(A–C) and decidua (D–F). A. LAMP1 localization in placental villous. B. LAMP1 localized to the cell column (cc), syncytiotrophoblast (s) and
leukocytes in the villous stroma (arrowhead). C. LAMP1 co-localized with HLAG positive cells (arrows) in the cell column (cc). D. The decidual glandular
epithelium (ge) was predominantly negative for LAMP1, but LAMP1 immunocolalized to the occasional glandular epithelial cell (*) and to HLAG
negative cells in the stroma (arrowhead). E. LAMP1 localized to HLAG negative cells surrounding unremodelled blood vessels (bv). F. LAMP1 localized
to EVT (arrows) surrounding remodelled blood vessels (bv). G. LAMP1 and HLAG co-localization (arrows) in the decidua basalis. H. Negative (IgG)
control for placental villous. I. Negative (IgG) control for decidua. Scale bar: 50 mm.
doi:10.1371/journal.pone.0031418.g008
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mechanisms leading to disease states.
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